Abstract:
Samuel Straface is betting that nanotechnology originally designed to repair military vehicles can be successfully used for something far different: to kill cancer tumors. Straface is president and CEO of Triton BioSystems Inc. in Chelmsford, a 3-year-old biotechnology/medical device company hybrid. And he believes the company's system will essentially fry a tumor without significant side effects, ultimately helping to treat patients in lieu of toxic chemotherapy or radiation.